Three-year follow-up of clinical and inflammation parameters in children monosensitized to mites undergoing sub-lingual immunotherapy

Pediatric Allergy and Immunology

Volumn 16, Issue 6, 2005, Pages 519-526

  Marcucci, F ^a   Sensi, L ^a   Di Cara, G ^a   Salvatori, S ^a   Bernini, M ^a   Pecora, S ^b   Burastero, S E ^c  

^a UNIVERSITY OF PERUGIA   (Italy)

^b ALK Abello Group   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Asthma; IgE (immunoglobulin E); Immunologic tests; Immunotherapy; Pediatrics; Rhinitis

Indexed keywords

EOSINOPHIL CATIONIC PROTEIN; HOUSE DUST ALLERGEN; IMMUNOGLOBULIN E; PLACEBO; TRYPTASE;

ADOLESCENT; ARTICLE; ASTHMA; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DERMATOPHAGOIDES; DOUBLE BLIND PROCEDURE; DRUG USE; FOLLOW UP; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOTHERAPY; INFLAMMATION; NOSE PROVOCATION TEST; NOSE SECRETION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINITIS; SENSITIZATION; SPUTUM ANALYSIS; TREATMENT OUTCOME;

ADMINISTRATION, SUBLINGUAL; ADOLESCENT; ANIMALS; ANTI-ASTHMATIC AGENTS; ANTIBODY SPECIFICITY; ASTHMA; CHILD; CHILD WELFARE; CHILD, PRESCHOOL; DESENSITIZATION, IMMUNOLOGIC; DOUBLE-BLIND METHOD; EOSINOPHIL CATIONIC PROTEIN; FOLLOW-UP STUDIES; HISTAMINE H1 ANTAGONISTS; HUMANS; IMMUNIZATION; IMMUNOGLOBULIN E; INFLAMMATION MEDIATORS; PYROGLYPHIDAE; RHINITIS, ALLERGIC, PERENNIAL; SERINE ENDOPEPTIDASES; TRYPTASES;

EID: 26244462106     PISSN: 09056157     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3038.2005.00301.x     Document Type: Article

References (38)

1. TARI MG, MANCINO M, MONTI G. Efficacy of sublingual immunotherapy in patients with rhinitis and asthma due to house dust mite. A double-blind study. Allergol Immunopathol (Madr) 1990: 18: 277-84.
2. TROISE C, VOLTOLINI S, CANESSA A, PECORA S, NEGRINI AC. Sublingual immunotherapy in Parietaria pollen-induced rhinitis: a double-blind study. J Investig Allergol Clin Immunol 1995: 5: 25-30.
3. SABBAH A, HASSOUN S, LE SELLIN J, ANDRE C, SICARD H. A double-blind, placebo-controlled trial by the sublingual route of immunotherapy with a standardized grass pollen extract. Allergy 1994: 49: 309-13.
4. CLAVEL R, BOUSQUET J, ANDRE C. Clinical efficacy of sublingual-swallow immunotherapy: a double-blind, placebo-controlled trial of a standardized five-grass-pollen extract in rhinitis. Allergy 1998: 53: 493-8.
5. FELIZIANI V, LATTUADA G, PARMIANI S, DALL'AGLIO PP. Safety and efficacy of sublingual rush immunotherapy with grass allergen extracts. A double blind study. Allergol Immunopathol (Madr) 1995: 23: 224-30.
6. QUIRING T, IEMOLI E, SICILIANI E, PARMIANI S, MILAZZO F. Sublingual versus injective immunotherapy in grass pollen allergic patients: a double blind (double dummy) study. Clin Exp Allergy 1996: 26: 1253-61.
7. PASSALACQUA G, ALBANO M, FREGONESE L, et al. Randomised controlled trial of local allergoid immunotherapy on allergic inflammation in mite-induced rhinoconjunctivitis. Lancet 1998: 351: 629-32.
8. VOURDAS D, SYRIGOU E, POTAMIANOU P, et al. Double-blind, placebo-controlled evaluation of sublingual immunotherapy with standardized olive pollen extract in pediatric patients with allergic rhinoconjunctivitis and mild asthma due to olive pollen sensitization. Allergy 1998: 53: 662-72.
9. BOUSQUET J, SCHEINMANN P, GUINNEPAIN MT, et al. Sublingual-swallow immunotherapy (SLIT) in patients with asthma due to house-dust mites: a double-blind, placebo-controlled study. Allergy 1999: 54: 249-60.
10. CANONICA GW, PASSALACQUA G. Noninjection routes for immunotherapy. J Allergy Clin Immunol 2003: 111: 437-48 (quiz 449).
11. BOUSQUET J, LOCKEY R, MALLING HJ. Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper. J Allergy Clin Immunol 1998: 102: 558-62.
12. BOUSQUET J, VAN CAUWENBERGE P, KHALTAEV N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001: 108: S147-334.
13. HOLT PG, VINES J, BRITTEN D. Sublingual allergen administration. I. Selective suppression of IgE production in rats by high allergen doses. Clin Allergy 1988: 18: 229-34.
14. LA ROSA M, RANNO C, ANDRE C, CARAT F, TOSCA MA, CANONICA GW. Double-blind placebo-controlled evaluation of sublingual-swallow immunotherapy with standardized Parietaria judaica extract in children with allergic rhinoconjunctivitis. J Allergy Clin Immunol 1999: 104: 425-32.
15. PRADALIER A, BASSET D, CLAUDEL A, et al. Sublingual-swallow immunotherapy (SLIT) with a standardized five-grass-pollen extract (drops and sublingual tablets) versus placebo in seasonal rhinitis. Allergy 1999: 54: 819-28.
16. PAJNO GB, MORABITO L, BARBERIO G, PARMIANI S. Clinical and immunologic effects of long-term sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, placebo-controlled study. Allergy 2000: 55: 842-9.
17. NELSON HS, OPPENHEIMER J, VATSIA GA, BUCHMEIER A. A double-blind, placebo-controlled evaluation of sublingual immunotherapy with standardized cat extract. J Allergy Clin Immunol 1993: 92: 229-36.
18. CASANOVAS M, GUERRA F, MORENO C, MIGUEL R, MARANON F, DAZA JC. Double-blind, placebo-controlled clinical trial of preseasonal treatment with allergenic extracts of Olea europaea pollen administered sublingually. J Investig Allergol Clin Immunol 1994: 4: 305-14.
19. FANTA C, BOHLE B, HIRT W, et al. Systemic immunological changes induced by administration of grass pollen allergens via the oral mucosa during sublingual immunotherapy. Int Arch Allergy Immunol 1999: 120: 218-24.
20. FREW AJ, SMITH HE. Sublingual immunotherapy. J Allergy Clin Immunol 2001: 107: 441-4.
21. MARCUCCI F, SENSI L, FRATI F, et al. Sublingual tryptase and ECP in children treated with grass pollen sublingual immunotherapy (SLIT): safety and immunologic implications. Allergy 2001: 56: 1091-5.
22. MARCUCCI F, SENSI L, FRATI F, et al. Effects on inflammation parameters of a double-blind, placebo controlled one-year course of SLIT in children mono-sensitized to mites. Allergy 2003: 58: 657-62.
23. SENSI LG, SERI A, SIRACUSA A, PERTICI L, MARCUCCI F. Allergic rhinitis in children: effects of flunisolide and disodium cromoglycate on nasal eosinophil cationic protein. Clin Exp Allergy 1997: 27: 270-6.
24. MARCUCCI F, SENSI L. A new method for IgE detection in nasal mucosa. Clin Exp Allergy 1989: 19: 157-62.
25. MARCUCCI F, SENSI LG, MIGALI E, CONIGLIO G. Eosinophil cationic protein and specific IgE in serum and nasal mucosa of patients with grass-pollen- allergic rhinitis and asthma. Allergy 2001: 56: 231-6.
26. MALLING HJ, ABREU-NOGUEIRA J, ALVAREZ-CUESTA E, et al. Local immunotherapy. Allergy 1998: 53: 933-44.
27. HOLT PG, SLY PD, SMITH W. Sublingual immunotherapy for allergic respiratory disease. Lancet 1998: 351: 613-4.
28. LIMA MT, WILSON D, PITKIN L, et al. Grass pollen sublingual immunotherapy for seasonal rhinoconjunctivitis: a randomized controlled trial. Clin Exp Allergy 2002: 32: 507-14.
29. WILSON DR, NOURI-ARIA KT, WALKER SM, et al. Grass pollen immunotherapy: symptomatic improvement correlates with reductions in eosinophils and IL-5 mRNA expression in the nasal mucosa during the pollen season. J Allergy Clin Immunol 2001: 107: 971-6.
30. HIRSCH T, SAHN M, LEUPOLD W. Double-blind placebo-controlled study of sublingual immunotherapy with house dust mite extract (D.pt.) in children. Pediatr Allergy Immunol 1997: 8: 21-7.
31. CIPRANDI G, BUSCAGLIA S, PESCE G, et al. Minimal persistent inflammation is present at mucosal level in patients with asymptomatic rhinitis and mite allergy. J Allergy Clin Immunol 1995: 96: 971-9.
32. RICCA V, LANDI M, FERRERO P, et al. Minimal persistent inflammation is also present in patients with seasonal allergic rhinitis. J Allergy Clin Immunol 2000: 105: 54-7.
33. BOUSQUET J. Sublingual immunotherapy: from proven prevention to putative rapid relief of allergic symptoms. Allergy 2005: 60: 1-3.
34. SILVESTRI M, ROSSI GA, COZZANI S, PULVIRENTI G, FASCE L. Age-dependent tendency to become sensitized to other classes of aeroallergens in atopic asthmatic children. Ann Allergy Asthma Immunol 1999: 83: 335-40.
35. PAJNO GB, BARBERIO G, DE LUCA F, MORABITO L, PARMIANI S. Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study. Clin Exp Allergy 2001: 31: 1392-7.
36. NOVEMBRE E, GALLI E, LANDI F, et al. Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis. J Allergy Clin Immunol 2004: 114: 851-7.
37. MAROGNA M, FALAGIANI P, BRUNO M, MASSOLO A, RIVA G. The allergic march in pollinosis: natural history and therapeutic implications. Int Arch Allergy Immunol 2004: 135: 336-42.
38. GORE C, CUSTOVIC A. Can we prevent allergy? Allergy 2004: 59: 151-61.